General Medicine

© Anthony Lee

LDN use for MS

  1. Jennifer Gerics


Top
1.   Jun 8, 2007 6:09 AM

» Feature Writer Jennifer Gerics - LDN

For anyone looking for information on LDN for MS, here is the latest statement from the National MS Society, which looks promising:


http://www.nationalmssociety.org/site/Pa...
Also, a new article from "Autoimmune Disorders" writer Elaine Moore, addressing the topic:
http://autoimmunedisease.suite101.com/ar...
And latest information on clinical trials that are under way:http://thecompounder.com/msnaltrexonetri...


Hopefully such trials will be successful and prove the drug safe for worldwide use. It's hard before new medications are studied because researchers don't know the long-term effects from such drugs, or which populations they are appropriate for. Tysabri sounded like a wonder drug until 2 people died after clinical trials, so now there are exceptions to who can take it. It needs to also be seen whether LDN works to prevent new attacks (disease-modifying), works to reduce or eliminate current symptoms, or (ideally) does both jobs. LDN sounds promising, and hopefully will be safe in the long run. If something is supposed to be a wonder drug, like LDN, it's important for it to be proven safe. The goal is EFFECTIVE and SAFE treatment, for the long run. Let's crosss our fingers!

Suite101
Feature Writer Jennifer Gerics
Feature Writer for Women’s Health


Post this Discussion Post to facebook Add this Discussion Post to del.icio.us! Digg this Discussion Post furl this Discussion Post Add this Discussion Post to Reddit Add this Discussion Post to Technorati Add this Discussion Post to Newsvine Add this Discussion Post to Windows Live Add this Discussion Post to Yahoo Add this Discussion Post to StumbleUpon Add this Discussion Post to BlinkLists Add this Discussion Post to Spurl Add this Discussion Post to Google Add this Discussion Post to Ask Add this Discussion Post to Squidoo


Please follow the guidelines set forth in the Suite101 Posting Etiquette when adding to the discussion.